Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity

Marion David, Irma Machuca-Gayet, Junichi Kikuta, Penelope Ottewell, Fuka Mima, Raphael Leblanc, Edith Bonnelye, Johnny Ribeiro, Ingunn Holen, Rùben Lopez Vales, Pierre Jurdic, Jerold Chun, Philippe Clézardin, Masaru Ishii, Olivier Peyruchaud

Producción científica: Contribución a una revistaArtículoInvestigación

42 Citas (Scopus)

Resumen

Background: Lysophosphatidic acid (LPA) is a bioactive lipid with pleiotropic activities due to activation of six receptors (LPA1-6). Results: Genetic deletion and pharmacological blockade of LPA1 inhibit differentiation and bone degradation activity of osteoclasts. Conclusion: LPA controls bone homeostasis through the activation of LPA1 expressed by osteoclasts. Significance: LPA1 is a new therapeutic target of diseases with excess bone degradation. © 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
Idioma originalInglés
Páginas (desde-hasta)6551-6564
PublicaciónJournal of Biological Chemistry
Volumen289
N.º10
DOI
EstadoPublicada - 7 mar 2014

Huella

Profundice en los temas de investigación de 'Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity'. En conjunto forman una huella única.

Citar esto